(Q35622850)

9 August 2017

1 reference

title

High-dose therapy and bone marrow transplantation in cutaneous T-cell lymphoma (English)

1 reference

9 August 2017

4

Richard K Burt

1 reference

9 August 2017

Yu Oyama

1

1 reference

9 August 2017

Joan Guitart

series ordinal

2

1 reference

9 August 2017

Timothy M Kuzel

series ordinal

3

1 reference

9 August 2017

Steven T Rosen

series ordinal

5

1 reference

9 August 2017

1 December 2003

1 reference

Hematology / Oncology Clinics of North America

9 August 2017

1 reference

9 August 2017

17

1 reference

9 August 2017

6

1 reference

9 August 2017

1475-83, xi

1 reference

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

High-dose carmustine, etoposide, and cisplatin and autologous bone marrow transplantation for relapsed and refractory lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Salvage therapy for relapsed or refractory non-Hodgkin's lymphoma utilizing autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Chromosome 13 abnormalities identified by FISH analysis and serum beta2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

T-cell depletion and autologous stem cell transplantation in the management of tumour stage mycosis fungoides with peripheral blood involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Erythrodermic mycosis fungoides treated with total body irradiation and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Treatment of advanced mycosis fungoides by allogeneic stem-cell transplantation with a nonmyeloablative regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Induction of complete remission of advanced stage mycosis fungoides by allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Long-term remission after allogeneic hematopoietic stem cell transplantation for refractory cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2803%2900114-X

7 January 2021

10.1016/S0889-8588(03)00114-X

Identifiers

DOI

1 reference

9 August 2017

1 reference